Series EHealthUnited StatesJun 09, 2026

GT Medical Technologies raises $100.0M Series E (United States, Jun 2026)

$100.0M
$100M Series E
Browse investors in United States →
Generated social card
GT Medical Technologies social card
Headline

GT Medical Technologies Raises $100M Series E to Advance Brain Tumour Therapy - Ventureburn

About

GT Medical Technologies develops innovative treatments for brain tumor patients, focusing on improving survival outcomes and quality of life. Their flagship product, GammaTile therapy, delivers immediate targeted radiation at the tumor site during surgery, aiming to reduce tumor regrowth and limit exposure to healthy brain tissue.

Article summary

GT Medical Technologies Raises $100M Series E to Advance Brain Tumour Therapy  Ventureburn

Investors · 6
4 hidden
Viking Global InvestorsLead
FUND
MVM Partners
FUND
Sign up free · see all 6 investors
Related rounds
Jun 09, 2026Orbital$5.0MPre-seedUnited States
Jun 09, 2026Morpho$175.0M—United States
Jun 09, 2026Vinyl Equity$20.0M—United States
Jun 09, 2026NinjaOne$400.0M—United States